메뉴 건너뛰기




Volumn 47, Issue 4, 2004, Pages 315-318

HRT as secondary prevention of cardiovascular disease

Author keywords

Cardiovascular diseases; HRT; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONJUGATED ESTROGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ESTRADIOL; GESTAGEN; GESTODENE; MEDROXYPROGESTERONE ACETATE; PLACEBO;

EID: 1942439747     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2003.10.014     Document Type: Conference Paper
Times cited : (12)

References (13)
  • 1
    • 0033672651 scopus 로고    scopus 로고
    • Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution
    • Ylikorkala O. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution. Acta Obstet. Gynecol. Scand. 79:2000;1029-1036.
    • (2000) Acta Obstet. Gynecol. Scand. , vol.79 , pp. 1029-1036
    • Ylikorkala, O.1
  • 2
    • 0036717719 scopus 로고    scopus 로고
    • Consequenses for HRT following the HERS II and WHI reports: The primum non nocere is important, but translation into quo vadis is even more essential
    • Skouby S.O. Consequenses for HRT following the HERS II and WHI reports: the primum non nocere is important, but translation into quo vadis is even more essential. Acta Obstet. Gynecol. Scand. 81:2002;793-798.
    • (2002) Acta Obstet. Gynecol. Scand. , vol.81 , pp. 793-798
    • Skouby, S.O.1
  • 3
    • 0032547326 scopus 로고    scopus 로고
    • Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    • Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B.et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
    • (1998) JAMA , vol.280 , pp. 605-613
    • Hulley, S.1    Grady, D.2    Bush, T.3    Furberg, C.4    Herrington, D.5    Riggs, B.6
  • 4
    • 0035800025 scopus 로고    scopus 로고
    • Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study
    • Grodstein F., Manson J.E., Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the Nurses' Health Study. Ann. Intern. Med. 135:2001;1-8.
    • (2001) Ann. Intern. Med. , vol.135 , pp. 1-8
    • Grodstein, F.1    Manson, J.E.2    Stampfer, M.J.3
  • 5
    • 0035818567 scopus 로고    scopus 로고
    • Hormone replacement therapy and in-hospital survival after myocardial infarction in postmenopausal women
    • Shlipak J., Angeja B.G., Go A.S., Frederick P.D., Canto J.G., Grady D. Hormone replacement therapy and in-hospital survival after myocardial infarction in postmenopausal women. Circulation. 104:2001;2300-2304.
    • (2001) Circulation , vol.104 , pp. 2300-2304
    • Shlipak, J.1    Angeja, B.G.2    Go, A.S.3    Frederick, P.D.4    Canto, J.G.5    Grady, D.6
  • 6
    • 1942480763 scopus 로고    scopus 로고
    • Hormone replacement therapy and stroke: Risk, protection or no effect
    • Paganini-Hull A. Hormone replacement therapy and stroke: risk, protection or no effect. Maturitas. 42:2002;11-29.
    • (2002) Maturitas , vol.42 , pp. 11-29
    • Paganini-Hull, A.1
  • 7
    • 0037014584 scopus 로고    scopus 로고
    • Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II)
    • Grady D., Herrington D., Bittner V., Blumenthal R., Davidson M., Hlatky M.et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). Jama. 288:2002;49-57.
    • (2002) Jama , vol.288 , pp. 49-57
    • Grady, D.1    Herrington, D.2    Bittner, V.3    Blumenthal, R.4    Davidson, M.5    Hlatky, M.6
  • 9
    • 0035808009 scopus 로고    scopus 로고
    • Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial
    • Hodis H.N., Mack W.J., Lobo R.A., Shoupe D., Sevanian A., Mahrer P.R.et al. Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 135:2001;939-953.
    • (2001) Ann. Intern. Med. , vol.135 , pp. 939-953
    • Hodis, H.N.1    MacK, W.J.2    Lobo, R.A.3    Shoupe, D.4    Sevanian, A.5    Mahrer, P.R.6
  • 10
    • 0035144266 scopus 로고    scopus 로고
    • Effects of oral postmenopausal hormone replacement on progression of atherosclerosis. A randomized controlled trial
    • Angerer P., Störk S., Kothny W., Schmitt P., von Schacky C. Effects of oral postmenopausal hormone replacement on progression of atherosclerosis. A randomized controlled trial. Atheroscler. Thromb. Vasc. Biol. 21:2001;262-268.
    • (2001) Atheroscler. Thromb. Vasc. Biol. , vol.21 , pp. 262-268
    • Angerer, P.1    Störk, S.2    Kothny, W.3    Schmitt, P.4    Von Schacky, C.5
  • 12
    • 0037125379 scopus 로고    scopus 로고
    • Risk and benefits of estrogen plus progestin in healthy postmenopausal woman
    • Writing Group for the Women's Health Initiative Investigators. Risk and benefits of estrogen plus progestin in healthy postmenopausal woman. JAMA 2002;288:321-33.
    • (2002) JAMA , vol.288 , pp. 321-333
  • 13
    • 0037199722 scopus 로고    scopus 로고
    • Results from WHI and HERS II - Implications for women and the prescriber of HRT
    • Neves-e-Castro M., Samsioe G., Dören M., Skouby S.O. Results from WHI and HERS II - implications for women and the prescriber of HRT. Maturitas. 42:2002;255-258.
    • (2002) Maturitas , vol.42 , pp. 255-258
    • Neves-E-Castro, M.1    Samsioe, G.2    Dören, M.3    Skouby, S.O.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.